Organic Letters
Letter
(3) Guidotti, T. L. Int. J. Toxicol. 2010, 29, 569−581.
adenosylmethyonine (SAM, a CBS activator), and amino-
oxyacetic acid (AOAA, a CBS inhibitor). SeP2 was loaded into
each experiment before or after treatments (see detailed
protocols in the Supporting Information). Fluorescence
intensities were measured by a plate reader and compared to
both negative and positive controls. As shown in Figure 6, cells
(4) Kolluru, G. K.; Shen, X.; Bir, S. C.; Kevil, C. G. Nitric Oxide 2013,
35, 5.
(5) Wang, R. Physiol. Rev. 2012, 92, 791.
(6) Kabil, O.; Banerjee, R. J. Biol. Chem. 2010, 285, 21903.
(7) Kabil, O.; Banerjee, R. Antioxid. Redox. Signal. 2014, 20, 770.
(8) Kimura, H. Amino Acids 2011, 41, 113.
(9) Kabil, O.; Motl, N.; Banerjee, R. Biochim. Biophys. Acta 2014,
1844, 1355.
(10) Ríos-Gonzal
Garriga, J. J. Inorg. Biochem. 2014, 133, 78.
(11) Hancock, J. T.; Whiteman, M. Plant Physiol. Biochem. 2014, 78,
37.
́ ́ ́
ez, B. B.; Roman-Morales, E. M.; Pietri, R.; Lopez-
(12) (a) Bibli, S.-I.; Yang, G.; Zhou, Z.; Wang, R.; Topouzis, S.;
Papapetropoulos, A. Nitric Oxide 2014, DOI: 10.1016/
j.niox.2014.12.004. (b) Ono, K.; Akaike, T.; Sawa, T.; Kumagai, Y.;
Wink, D. A.; Tantillo, D. J.; Hobbs, A. J.; Nagy, P.; Xian, M.; Lin, J.;
Fukuto, J. M. Free Radical Biol. Med. 2014, 77, 82.
(13) (a) Peng, H.; Chen, W.; Cheng, Y.; Hakuna, L.; Strongin, R.;
Wang, B. Sensors 2012, 12, 15907. (b) Pluth, M. D.; Bailey, T. S.;
Hammers, M. D.; Montoya, L. A. Biochalcogen Chemistry: The
Biological Chemistry of Sulfur, Selenium, and Tellurium, Vol. 1152;
Baysel, C. A., Brumaghim, J. L., Eds.; American Chemical Society:
Washington, DC, 2013; p 15. (c) Lin, V. S.; Chen, W.; Xian, M.;
Chang, C. J. Chem. Soc. Rev. 2015, DOI: 10.1039/C4CS00298A.
(d) Peng, B.; Xian, M. Asian J. Org. Chem. 2014, 3, 914. (e) Li, X.;
Gao, X.; Shi, W.; Ma, H. Chem. Rev. 2014, 114, 590.
Figure 6. Fluorescent detection of in situ generated H2S in human
neuroblastoma cells (*P < 0.05, **P < 0.01, ***P < 0.001 vs control;
N = 5 each).
(14) (a) Lippert, A. R.; New, E. J.; Chang, C. J. J. Am. Chem. Soc.
2011, 133, 10078. (b) Peng, H.; Cheng, Y.; Dai, C.; King, A. L.;
Predmore, B. L.; Lefer, D. J.; Wang, B. Angew. Chem., Int. Ed. 2011, 50,
9672. (c) Wan, Q.; Song, Y.; Li, Z.; Gao, X.; Ma, H. Chem. Commun.
2013, 49, 502. (d) Zhang, J.; Guo, W. Chem. Commun. 2014, 50, 4214.
(15) (a) Liu, C.; Pan, J.; Li, S.; Zhao, Y.; Wu, L. Y.; Berkman, C. E.;
Whorton, A. R.; Xian, M. Angew. Chem., Int. Ed. 2011, 50, 10327.
(b) Peng, B.; Chen, W.; Liu, C.; Rosser, E. W.; Pacheco, A.; Zhao, Y.;
Aguilar, H. C.; Xian, M. Chem.Eur. J. 2014, 20, 1010.
treated with H2S substrates or CBS activator showed clearly
enhanced fluorescence while cells treated with CBS inhibitor
showed decreased fluorescence. Not surprisingly cells treated
with Na2S showed the strongest fluorescence. These results
suggest that SeP2 can be used in determining endogenous H2S
changes.
In conclusion, we reported herein a unique reaction between
phenyl diselenide and H2S to form 1,2-benzothiaselenol-3-one.
The presence of thiols did not affect this process. Based on this
reaction two fluorescent probes for the detection of H2S were
prepared and evaluated. The probes showed excellent
sensitivity and selectivity.
(16) (a) Qian, Y.; Karpus, J.; Kabil, O.; Zhang, S. Y.; Zhu, H. L.;
Banerjee, R.; Zhao, J.; He, C. Nat. Commun. 2011, 2, 495. (b) Liu, J.;
Sun, Y.-Q.; Zhang, J.; Yang, T.; Cao, J.; Zhang, L.; Guo, W. Chem.
Eur. J. 2013, 19, 4717. (c) Chen, Y.; Zhu, C.; Yang, Z.; Chen, J.; He,
Y.; Jiao, Y.; He, W.; Qiu, L.; Cen, J.; Guo, Z. Angew. Chem., Int. Ed.
2013, 52, 1688.
ASSOCIATED CONTENT
* Supporting Information
■
(17) (a) Sasakura, K.; Hanaoka, K.; Shibuya, N.; Mikami, Y.; Kimura,
Y.; Komatsu, T.; Ueno, T.; Terai, T.; Kimura, H.; Nagano, T. J. Am.
Chem. Soc. 2011, 133, 10629. (b) Hou, F.; Cheng, J.; Xi, P.; Chen, F.
L.; Huang, G.; Xie, Y.; Shi, H.; Liu, D.; Bai, Z.; Zeng. Dalton Trans.
2012, 41, 5799.
(18) (a) Furne, J.; Saeed, A.; Levitt, M. D. Am. J. Physiol Regul Integr
Comp Physiol 2008, 295, R1479. (b) Whiteman, M.; Trionnaire, S. L.;
Chopra, M.; Fox, B.; Whatmore, J. Clinical Science 2011, 121, 459.
(19) Steinmann, D.; Nauser, T.; Koppenol, W. H. J. Org. Chem. 2010,
75, 6696.
(20) Bachrach, S. M.; Demoin, D. W.; Luk, M.; Miller, J. V. J. Phys.
Chem. A 2004, 108, 4040.
(21) (a) Beld, J.; Woycechowsky, K. J.; Hilvert, D. ACS Chem. Biol.
2010, 5, 177. (b) Joris Beld, J.; Woycechowsky, K. J.; Hilvert, D.
Biochemistry 2008, 47, 6985. (c) Metanis, N.; Hilvert, D. Angew. Chem.,
Int. Ed. 2012, 51, 5585.
S
Detailed synthetic procedures, characteristic data, and exper-
imental procedures. This material is available free of charge via
AUTHOR INFORMATION
Corresponding Author
■
Author Contributions
∥B.P. and C.Z. contributed equally to this work.
Notes
The authors declare no competing financial interest.
(22) Rasmussen, B.; Sørensen, A.; Gotfredsen, H.; Pittelkow, M.
Chem. Commun. 2014, 50, 3716.
ACKNOWLEDGMENTS
■
This work is supported by an American Chemical Society Teva
USA Scholar Grant and the NIH (R01HL101930 and
R01HL116571).
REFERENCES
■
(1) Li, L.; Moore, P. K. Annu. Rev. Pharmacol. Toxicol. 2011, 51, 169.
(2) Fukuto, J. M.; Carrington, S. J.; Tantillo, D. J.; Harrison, J. G.;
Ignarro, L. J.; Freeman, B. A.; Chen, A.; Wink, D. A. Chem. Res.
Toxicol. 2012, 25, 769.
D
Org. Lett. XXXX, XXX, XXX−XXX